Pre-hospital Risk Factors for Invasive Fungal Infection
Launched by CATHOLIC UNIVERSITY OF THE SACRED HEART · Mar 15, 2011
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
SEIFEM 2010:
EPIDEMIOLOGICAL SURVEY ON POSSIBLE PRE-HOSPITAL RISK FACTORS FOR DEVELOPING INVASIVE FUNGAL INFECTIONS IN PATIENTS AFFECTED BY ACUTE MYELOID LEUKEMIA
Background:
In two different multicenter surveys conducted in Italy from 1988-1997 and 1999-2003, (Invasive Fungal Infections) IFIs were found to be a frequent cause of morbidity and mortality in patients treated with conventional chemotherapies, particularly in those suffering from acute myeloid leukemia (AML).
In general, the major factors that have been recognized as influencing the likelihood of invasive fungal infection a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all newly diagnosed AML who accept to take part to the registry and sign an informed consent
- Exclusion Criteria:
- • relapsing/refractory AML
- • patients who do not sign informed consent
About Catholic University Of The Sacred Heart
The Catholic University of the Sacred Heart is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on ethical standards and community well-being, the university actively engages in clinical trials that contribute to innovative healthcare solutions. Its multidisciplinary approach leverages expertise from various fields, fostering collaborations that enhance the quality and impact of research. The university is dedicated to improving patient outcomes through rigorous science and compassionate care, aligning with its mission to serve the greater good.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Parma, , Italy
Perugia, , Italy
Rome, Rm, Italy
Palermo, , Italy
Udine, , Italy
Ancona, An, Italy
Bari, Ba, Italy
Bologna, Bo, Italy
Firenze, Fi, Italy
Tricase, Le, Italy
Milano, Mi, Italy
Rome, Rm, Italy
Rome, Rm, Italy
Rome, Rm, Italy
Rome, Rm, Italy
Torino, To, Italy
Brescia, , Italy
Cagliari, , Italy
Campobasso, , Italy
Cuneo, , Italy
Firenze, , Italy
Genova, , Italy
La Spezia, , Italy
Lecce, , Italy
Lecce, , Italy
Modena, , Italy
Monza, , Italy
Monza, , Italy
Napoli, , Italy
Napoli, , Italy
Napoli, , Italy
Pavia, , Italy
Pavia, , Italy
Perugia, , Italy
Pescara, , Italy
Reggio Calabria, , Italy
Reggio Emilia, , Italy
San Giovanni Rotondo, , Italy
Torino, , Italy
Torino, , Italy
Verona, , Italy
Verona, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials